JP Stock MarketDetailed Quotes
2395 Shin Nippon Biomedical Laboratories
- 1470
- +122+9.05%
20min DelayNot Open Nov 7 15:30 JST
61.20BMarket Cap11.06P/E (Static)
1476High1382Low1.28MVolume1383Open1348Pre Close1.81BTurnover199652wk High7.37%Turnover Ratio41.63MShares97052wk Low93.59EPS TTM25.46BFloat Cap3225Historical High11.06P/E (Static)17.32MShs Float185Historical Low132.86EPS LYR6.97%Amplitude50.00Dividend TTM1.68P/B100Lot Size3.40%Div YieldTTM
Shin Nippon Biomedical Laboratories Key Stats
EPS
According to the latest financial report of Shin Nippon Biomedical Laboratories, the latest earnings per share (TTM) for the company is 2.93. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about Shin Nippon Biomedical Laboratories's free cash flow? The latest report shows it as 288.19M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Shin Nippon Biomedical Laboratories shows that the company's current ratio is 1.18, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Shin Nippon Biomedical Laboratories, the quick ratio is 0.61, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of Shin Nippon Biomedical Laboratories? The latest ROE figure is 5.40%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Shin Nippon Biomedical Laboratories, the total asset return on investment (ROA) is 2.35%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Shin Nippon Biomedical Laboratories's latest financial report to see how their gross margin is doing - currently at 54.50%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Shin Nippon Biomedical Laboratories, the net profit margin is 2.06%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data